CGEN (cgen.com) Total Enterprise Value

Compugen Ltd. (CGEN) delegates initial drug trials to external contractors while retaining all patent rights. The business relies on a digital biological target discovery system, where the confirmation of antibody efficacy serves as the key success factor. This daily price action on GURU.Markets shows that the Separate Enterprise Value is 55.33. Market capitalization is growing due to payments from pharma behemoths for the use of unique AI developments.

CGEN (Compugen) Total Company Value history from 11/23/2025 to 10/27/2026

Compugen - analytical breakdowns and key metrics (CGEN)

- price and consensus price forecast:

Price Rate Chart Compugen Ltd|CGEN - Analyst Consensus Forecast

- market capitalization data:

Market Value Compugen|CGEN - Total Company Value

- book capitalization data:

Equity per Share Compugen|CGEN - Company Book Value|Market-to-Book Ratio cgen.com|CGEN - Aggregate Company Assets

- debt and liquidity data:

Debt to Equity Ratio Compugen Ltd.|CGEN - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Compugen Ltd|CGEN - Company Debts|Debts to Book Value Compugen

Fundamental valuation:Compugen Ltd. (CGEN)

Analyzing historical EV levels allows for an assessment of Compugen Ltd. (CGEN) as a high-tech player in the immunotherapy sector. This metric determines the total acquisition cost of the business by summing market capitalization and debt minus liquid assets, which, combined with a unique protein modeling platform, confirms the high value of intellectual barriers and the fundamental resilience of the company.

Competitors of Compugen Ltd. (CGEN)

Full Takeover Company Value ImmunityBio Inc IBRX|IMCR (Immunocore PLC) - Enterprise Value|JANX: Total Enterprise Value|Total Company Value Arcus Biosciences, Inc.|ZYME (zymeworks.com) - Business Value|Total Company Value TNGX (Tango Therapeutics, Inc.)|Total Enterprise Value IOVA|Total Company Value Immatics Corp IMTX|Business Value Xencor Inc. (XNCR)|Compass Therapeutics - Enterprise Value|replimune.com - Real Price to Acquire Entire Company|LYEL (Lyell Immunopharma, Inc.) - Total Company Value|IPHA: Total Enterprise Value|pyxisoncology.com (PYXS) - Total Company Value|IOBT (IO Biotech Inc.) - Total Company Value|Total Company Value STRO (Sutro Biopharma, Inc.)|Total Enterprise Value minktherapeutics.com|HOWL: Enterprise Value|Full Takeover Company Value immixbio.com IMMX|ALXO: Real Price to Acquire Entire Company|CUE - Total Enterprise Value|Real Price to Acquire Entire Company PDS Biotechnology Corp (PDSB)|SONN - Value Adjusted for Debt and Cash|MAIA Biotechnology, Inc. - Enterprise Value|LIMN (Liminatus Pharma Inc.) - Company Buyout Price|Total Company Value LVTX|Real Price to Acquire Entire Company NXTC|Total Company Value LPTX (Leap Therapeutics, Inc.)|Real Price to Acquire Entire Company intensitytherapeutics.com INTS|Real Price to Acquire Entire Company SNSE (Sensei Biotherapeutics, Inc.)|Theriva Biologics Inc - Enterprise Value|Gritstone Bio (GRTS) - Total Company Value|KA: Business Value|Total Company Value NEXI|Total Enterprise Value Turnstone Biologics Corp.|Vaccinex - Real Price to Acquire Entire Company|Full Takeover Company Value Harpoon Therapeutics Inc (HARP)